Willem M Lijfering


Affiliation: University Medical Center Groningen
Country: The Netherlands


  1. Lijfering W, Sprenger H, van Son W, van der Meer J. Mesenteric vein thrombosis associated with primary cytomegalovirus infection: a case report. Blood Coagul Fibrinolysis. 2007;18:509-11 pubmed
    ..We discuss the possible mechanisms of cytomegalovirus-related venous thrombosis. ..
  2. Lijfering W, Sprenger H, Georg R, van der Meulen P, van der Meer J. Relationship between progression to AIDS and thrombophilic abnormalities in HIV infection. Clin Chem. 2008;54:1226-33 pubmed publisher
    ..The frequencies of these thrombophilic abnormalities increase with the progression to AIDS. These findings may contribute to the high prevalence of venous and arterial thrombosis in HIV-infected patients. ..
  3. Lijfering W, Brouwer J, Veeger N, Bank I, Coppens M, Middeldorp S, et al. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood. 2009;113:5314-22 pubmed publisher
  4. Lijfering W, Middeldorp S, Veeger N, Hamulyak K, Prins M, Buller H, et al. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Circulation. 2010;121:1706-12 pubmed publisher
    ..In this study, individuals with homozygous factor V Leiden and/or homozygous prothrombin G20210A or double heterozygous carriers of factor V Leiden and prothrombin G20210A did not have a high risk of recurrent venous thrombosis. ..